Movement Alert｜Humana Rises 6.95% in Regular Trading, Company Reaffirms Full-Year Earnings Guidance Above Consensus

Market Focus06-02 00:14

On June 1, Humana rose 6.95% in regular trading, trading at $326.84/share, with trading volume of $271 million. The stock surged after the company announced it plans to reaffirm its full-year adjusted earnings guidance during upcoming investor meetings.

Humana stated that it will reaffirm full-year adjusted earnings guidance of at least $9 per share at various meetings scheduled throughout June, exceeding the analyst consensus estimate of $8.93 per share. The guidance reaffirmation signals management confidence in the company's operational trajectory following its strong Q1 earnings of $10.31 per share reported in late April.

The move also follows multiple analyst target price increases. Barclays significantly raised its target from $180 to $344 while maintaining an equal-weight rating, and Truist lifted its target from $270 to $320 while keeping a hold rating. The average analyst target price stands at approximately $268, well below the current trading level. Despite the broader healthcare sector trading slightly lower on the day, Humana outperformed peers within the Managed Health Care space.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1196446952?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-02 00:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196446952","market":"us","top_or_hot":-1,"title":"Movement Alert｜Humana Rises 6.95% in Regular Trading, Company Reaffirms Full-Year Earnings Guidance Above Consensus","media":"Market Focus","content":"<p><p>On June 1, Humana rose 6.95% in regular trading, trading at $326.84/share, with trading volume of $271 million. The stock surged after the company announced it plans to reaffirm its full-year adjusted earnings guidance during upcoming investor meetings.</p><p>Humana stated that it will reaffirm full-year adjusted earnings guidance of at least $9 per share at various meetings scheduled throughout June, exceeding the analyst consensus estimate of $8.93 per share. The guidance reaffirmation signals management confidence in the company's operational trajectory following its strong Q1 earnings of $10.31 per share reported in late April.</p><p>The move also follows multiple analyst target price increases. Barclays significantly raised its target from $180 to $344 while maintaining an equal-weight rating, and Truist lifted its target from $270 to $320 while keeping a hold rating. The average analyst target price stands at approximately $268, well below the current trading level. Despite the broader healthcare sector trading slightly lower on the day, Humana outperformed peers within the Managed Health Care space.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Humana Rises 6.95% in Regular Trading, Company Reaffirms Full-Year Earnings Guidance Above Consensus</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Humana Rises 6.95% in Regular Trading, Company Reaffirms Full-Year Earnings Guidance Above Consensus\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-02 00:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 1, Humana rose 6.95% in regular trading, trading at $326.84/share, with trading volume of $271 million. The stock surged after the company announced it plans to reaffirm its full-year adjusted earnings guidance during upcoming investor meetings.</p><p>Humana stated that it will reaffirm full-year adjusted earnings guidance of at least $9 per share at various meetings scheduled throughout June, exceeding the analyst consensus estimate of $8.93 per share. The guidance reaffirmation signals management confidence in the company's operational trajectory following its strong Q1 earnings of $10.31 per share reported in late April.</p><p>The move also follows multiple analyst target price increases. Barclays significantly raised its target from $180 to $344 while maintaining an equal-weight rating, and Truist lifted its target from $270 to $320 while keeping a hold rating. The average analyst target price stands at approximately $268, well below the current trading level. Despite the broader healthcare sector trading slightly lower on the day, Humana outperformed peers within the Managed Health Care space.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HUM","symbol_name":"哈门那","start_time":0,"source_url":"","article_id":"1196446952","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196446952","pubTimestamp":1780330440,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 1, Humana rose 6.95% in regular trading, trading at $326.84/share, with trading volume of $271 million. The stock surged after the company announced it plans to reaffirm its full-year...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HUM":"哈门那"},"translate_title":"动向提示|Humana常规交易涨6.95%公司重申全年盈利指引高于共识","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HUM":1},"content_text":"On June 1, Humana rose 6.95% in regular trading, trading at $326.84/share, with trading volume of $271 million. The stock surged after the company announced it plans to reaffirm its full-year adjusted earnings guidance during upcoming investor meetings.Humana stated that it will reaffirm full-year adjusted earnings guidance of at least $9 per share at various meetings scheduled throughout June, exceeding the analyst consensus estimate of $8.93 per share. The guidance reaffirmation signals management confidence in the company's operational trajectory following its strong Q1 earnings of $10.31 per share reported in late April.The move also follows multiple analyst target price increases. Barclays significantly raised its target from $180 to $344 while maintaining an equal-weight rating, and Truist lifted its target from $270 to $320 while keeping a hold rating. The average analyst target price stands at approximately $268, well below the current trading level. Despite the broader healthcare sector trading slightly lower on the day, Humana outperformed peers within the Managed Health Care space.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1196446952","isCrawlerRequest":true}